Steffen Goletz
-
- Monoclonal and Polyclonal Antibodies Research 35
- Immunology top 5%
- Galectins and Cancer Biology 8
- Immunotherapy and Immune Responses 7
- Toxin Mechanisms and Immunotoxins 5
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 39
- Protein purification and stability 6
- Oncology top 10%
- HER2/EGFR in Cancer Research 7
- Biotechnology top 10%
-
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Uwe KarstenAntje DanielczykPeter KristensenStefan MüllerFranz‐Georg HanischYi CaoPeter Astrup ChristensenPhilippe Ulsemer
- Journals
- Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (2 papers)
- Partner nations
- GermanyDenmarkUnited States
In The Last Decade
Steffen Goletz
69 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 100
- Radiology, Nuclear Medicine and Imaging 646
- Immunology 588
- Molecular Biology 1.3k
- Oncology 343
- Biotechnology 91
Countries citing papers authored by Steffen Goletz
This map shows the geographic impact of Steffen Goletz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Goletz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Goletz more than expected).
Fields of papers citing papers by Steffen Goletz
This network shows the impact of papers produced by Steffen Goletz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Goletz. The network helps show where Steffen Goletz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steffen Goletz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 26 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 44 | |
| 8 | 2022 | 4 | |
| 9 | 2018 | 14 | |
| 10 | 2015 | 18 | |
| 11 | 2013 | 93 | |
| 12 | 2008 | 8 | |
| 13 | 2008 | 47 | |
| 14 | 2008 | 1 | |
| 15 | 2006 | 52 | |
| 16 | In vitro priming of tumor-specific cytotoxic T lymphocytes from healthy donors using allogeneic dendritic cells derived from the MUTZ-3 cell line (NMDC) | 2004 | 1 |
| 17 | 2004 | 36 | |
| 18 | 2003 | 29 | |
| 19 | 1997 | 16 | |
| 20 | 1997 | 38 |
About Steffen Goletz
Steffen Goletz is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Biotechnology, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (39 papers), Monoclonal and Polyclonal Antibodies Research (35 papers), Galectins and Cancer Biology (8 papers), Immunotherapy and Immune Responses (7 papers), HER2/EGFR in Cancer Research (7 papers), Protein purification and stability (6 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (646 citations), Immunology (588 citations) and Molecular Biology (1.3k citations). Steffen Goletz has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Uwe Karsten, Antje Danielczyk, Peter Kristensen, Stefan Müller, Franz‐Georg Hanisch, Yi Cao, Peter Astrup Christensen, Philippe Ulsemer, Renate Stahn and Anja Löffler. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.